Cormorant Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$39.4M Sell
2025
Q1
$57.8M Sell
2024
Q4
$83.5M Buy
2024
Q3
$41M Buy
2024
Q2
$44.2M Buy
2024
Q1
$35.5M Buy